Literature DB >> 9809127

On redefining hallucination.

A Aleman, E H de Haan.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9809127     DOI： 10.1037/h0080376

Source DB:  PubMed          Journal:  Am J Orthopsychiatry        ISSN： 0002-9432


× No keyword cloud information.
  5 in total

1.  Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations.

Authors:  Nadine Donata Wolf; Fabio Sambataro; Nenad Vasic; Karel Frasch; Markus Schmid; Carlos Schönfeldt-Lecuona; Philipp Arthur Thomann; Robert Christian Wolf
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

Review 2.  [Cognitive control in the research domain criteria system: clinical implications for auditory verbal hallucinations].

Authors:  Katharina M Kubera; Dusan Hirjak; Nadine D Wolf; Robert C Wolf
Journal:  Nervenarzt       Date:  2021-08-03       Impact factor: 1.214

3.  Neural Correlates of Auditory Verbal Hallucinations in Schizophrenia and the Therapeutic Response to Theta-Burst Transcranial Magnetic Stimulation.

Authors:  Xingui Chen; Gong-Jun Ji; Chunyan Zhu; Xiaomeng Bai; Lu Wang; Kongliang He; Yaxiang Gao; Longxiang Tao; Fengqiong Yu; Yanghua Tian; Kai Wang
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

Review 4.  Noninvasive brain stimulation for the treatment of auditory verbal hallucinations in schizophrenia: methods, effects and challenges.

Authors:  Katharina M Kubera; Anja Barth; Dusan Hirjak; Philipp A Thomann; Robert C Wolf
Journal:  Front Syst Neurosci       Date:  2015-10-12

5.  Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a 1H MRS study.

Authors:  Qianjin Wang; Honghong Ren; Chunwang Li; Zongchang Li; Jinguang Li; Hong Li; Lulin Dai; Min Dong; Jun Zhou; Jingqi He; Joseph O'Neill; Yanhui Liao; Ying He; Tieqiao Liu; Xiaogang Chen; Jinsong Tang
Journal:  Transl Psychiatry       Date:  2022-03-23       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.